Cohance Lifesciences Limited (BOM:543064)
997.50
-14.30 (-1.41%)
At close: Jul 30, 2025
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 374.67 billion as of August 1, 2025. Its market cap has increased by 71.42% in one year.
Market Cap
374.67B
Enterprise Value
376.09B
Revenue
11.98B
Ranking
n/a
PE Ratio
139.87
Stock Price
997.50
Market Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 374.67B, an increase of 1,111,506.97%. That is a compound annual growth rate of 461.37%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 374.67B | 29.25% |
Dec 31, 2024 | 289.89B | 57.55% |
Dec 29, 2023 | 184.00B | 46.05% |
Dec 30, 2022 | 125.98B | 0.33% |
Dec 31, 2021 | 125.56B | 9.05% |
Dec 31, 2020 | 115.14B | 341,510.23% |
Mar 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Reliance Industries | 17.92T |
HDFC Bank | 15.53T |
Bharti Airtel | 11.58T |
Tata Consultancy Services | 11.05T |
ICICI Bank | 10.58T |
State Bank of India | 7,400.35B |
Infosys | 6,296.52B |
Hindustan Unilever | 5,726.89B |